IDEAYA Biosciences (IDYA) Capital Expenditures Growth (1y) (2019 - 2026)
IDEAYA Biosciences (IDYA) Capital Expenditures Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,583.17 Bn | 67,582.89 Bn | - | 38.18% |
| 2 | Nanobiotix | 1,947.22 Bn | 1,947.15 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 473.21 Bn | 468.42 Bn | 1.35 Bn | -27.93% |
| 5 | Vertex Pharmaceuticals | 123.29 Bn | 116.04 Bn | 2.59 Bn | 227.76% |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.29 Bn | 3.31 Bn | 0.57% |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - | - |
| 8 | Argenx Se | 56.63 Bn | 51.45 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.79 Bn | 37.79 Bn | - | - |
| 10 | IDEAYA Biosciences | 3.25 Bn | 2.57 Bn | - | 47.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47.86% |
| Dec 31, 2025 | 765.17% |
| Sep 30, 2025 | -33.73% |
| Jun 30, 2025 | 37.62% |
| Mar 31, 2025 | -50.64% |
| Dec 31, 2024 | -76.01% |
| Sep 30, 2024 | -209.68% |
| Jun 30, 2024 | 766.44% |
| Mar 31, 2024 | 77.61% |
| Dec 31, 2023 | 127.39% |
| Sep 30, 2023 | -61.60% |
| Jun 30, 2023 | -131.00% |
| Mar 31, 2023 | 35.64% |
| Dec 31, 2022 | -605.62% |
| Sep 30, 2022 | 428.82% |
| Jun 30, 2022 | -60.68% |
| Mar 31, 2022 | 43.60% |
| Dec 31, 2021 | 193.69% |
| Sep 30, 2021 | 650.82% |
| Jun 30, 2021 | 444.55% |